Filing metadata

Accession number
0001839882-23-001530
Form type
Form 3
Filer
Summit Therapeutics Inc.
CIK
CIK 1599298
Filed
Jan 26, 2023
Reporting period
Jan 17, 2023
Description
Initial ownership

Explore SEC Filings Hub